Envista (NVST) Revenue & Revenue Breakdown
Envista Revenue Highlights
Latest Revenue (Y)
$2.57B
Latest Revenue (Q)
$884.70M
Main Segment (Y)
Specialty Products and Technologies
Main Geography (Y)
UNITED STATES
Envista Revenue by Period
Envista Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $2.57B | -0.10% |
2022-12-31 | $2.57B | 2.40% |
2021-12-31 | $2.51B | 9.94% |
2020-12-31 | $2.28B | -17.07% |
2019-12-31 | $2.75B | -3.27% |
2018-12-31 | $2.84B | 1.20% |
2017-12-31 | $2.81B | 0.92% |
2016-12-31 | $2.79B | - |
Envista Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-27 | $884.70M | 39.74% |
2024-06-28 | $633.10M | 1.52% |
2024-03-29 | $623.60M | -3.41% |
2023-12-31 | $645.60M | 2.27% |
2023-09-29 | $631.30M | -4.70% |
2023-06-30 | $662.40M | 5.61% |
2023-03-31 | $627.20M | -5.08% |
2022-12-31 | $660.80M | 4.71% |
2022-09-30 | $631.10M | -2.28% |
2022-07-01 | $645.80M | 2.28% |
2022-04-01 | $631.40M | -3.13% |
2021-12-31 | $651.80M | 7.33% |
2021-10-01 | $607.30M | -17.94% |
2021-07-02 | $740.10M | 4.36% |
2021-04-02 | $709.20M | -3.15% |
2020-12-31 | $732.30M | 14.33% |
2020-10-02 | $640.50M | 76.93% |
2020-07-03 | $362.00M | -33.85% |
2020-04-03 | $547.20M | -24.05% |
2019-12-31 | $720.50M | 9.28% |
2019-09-27 | $659.30M | -7.41% |
2019-06-30 | $712.10M | 7.94% |
2019-03-31 | $659.70M | -13.08% |
2018-12-31 | $759.00M | 11.70% |
2018-09-30 | $679.50M | -7.35% |
2018-06-30 | $733.40M | 9.04% |
2018-03-31 | $672.60M | - |
Envista Revenue Breakdown
Envista Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Equipment and Consumables | $924.10M | - | - | - | - |
Specialty Products and Technologies | $1.64B | - | - | - | - |
Consumables | - | $2.15B | $2.07B | $1.59B | $1.87B |
Equipment Sales | - | $421.60M | $441.00M | $687.90M | $881.70M |
Quarterly Revenue by Product
Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Apr 22 | Dec 21 | Oct 21 | Jul 21 | Apr 21 | Dec 20 | Oct 20 | Jul 20 | Apr 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Specialty Products and Technologies | $408.70M | $825.90M | $399.50M | $417.00M | $328.80M | $317.80M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Equipment and Consumables | $214.90M | $446.90M | $231.80M | $245.40M | $391.70M | $341.50M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Equipment Sales | - | - | - | - | $91.70M | $119.00M | $100.10M | $101.00M | $101.50M | $125.50M | $113.60M | $205.60M | $194.30M | $231.30M | $180.60M | $106.70M | $169.30M | - | - |
Consumables | - | - | - | - | $535.50M | $541.80M | $531.00M | $544.80M | $529.90M | $526.30M | $493.70M | $534.50M | $514.90M | $501.00M | $459.90M | $255.30M | $377.90M | - | - |
Envista Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
CHINA | $205.70M | $222.20M | $236.70M | $215.60M | $212.80M |
All Other Countries | $1.15B | $1.08B | $1.05B | $908.90M | $1.18B |
UNITED STATES | $1.21B | $1.26B | $1.22B | $1.01B | $1.21B |
GERMANY | - | - | - | $144.60M | $151.30M |
Quarterly Revenue by Country
Country | Sep 24 | Mar 24 | Sep 23 | Dec 21 | Dec 19 |
---|---|---|---|---|---|
Western Europe | $109.30M | $148.30M | $119.50M | $135.40M | $160.00M |
North America | $319.50M | $318.70M | $332.00M | $333.50M | $351.20M |
Envista Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ALC | Alcon | $10.09B | $2.46B |
RMD | ResMed | $4.69B | $1.22B |
HOLX | Hologic | $4.03B | $1.01B |
COO | Cooper Companies | $3.59B | $1.00B |
ATR | AptarGroup | $3.49B | $909.29M |
TFX | Teleflex | $2.97B | $764.38M |
WST | West Pharmaceutical Services | $2.95B | $746.90M |
NVST | Envista | $2.57B | $884.70M |
ICUI | ICU Medical | $2.26B | $596.46M |
HAE | Haemonetics | $1.31B | $336.17M |
MMSI | Merit Medical Systems | $1.26B | $339.85M |
ATRC | AtriCure | $399.25M | $115.91M |
ANGO | AngioDynamics | $303.91M | $67.49M |
AKYA | Akoya Biosciences | $96.63M | $23.16M |
ATRI | Atrion | - | $48.77M |
NVST Revenue FAQ
What is Envista’s yearly revenue?
Envista's yearly revenue for 2023 was $2.57B, representing a decrease of -0.10% compared to 2022. The company's yearly revenue for 2022 was $2.57B, representing an increase of 2.40% compared to 2021. NVST's yearly revenue for 2021 was $2.51B, representing an increase of 9.94% compared to 2020.
What is Envista’s quarterly revenue?
Envista's quarterly revenue for Q3 2024 was $884.7M, a 39.74% increase from the previous quarter (Q2 2024), and a 40.14% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $633.1M, a 1.52% increase from the previous quarter (Q1 2024), and a -4.42% decrease year-over-year (Q2 2023). NVST's quarterly revenue for Q1 2024 was $623.6M, a -3.41% decrease from the previous quarter (Q4 2023), and a -0.57% decrease year-over-year (Q1 2023).
What is Envista’s revenue growth rate?
Envista's revenue growth rate for the last 3 years (2021-2023) was 2.30%, and for the last 5 years (2019-2023) was -6.73%.
What are Envista’s revenue streams?
Envista's revenue streams in c 23 are Equipment and Consumables, and Specialty Products and Technologies. Equipment and Consumables generated $924.1M in revenue, accounting 36.01% of the company's total revenue Specialty Products and Technologies generated $1.64B in revenue, accounting 63.99% of the company's total revenue
What is Envista’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Envista was Specialty Products and Technologies. This segment made a revenue of $1.64B, representing 63.99% of the company's total revenue.